Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 699 29 060.0 |
96 | EP file number | EAKZ | 99 94 1027.7 |
86 | WO file number | WAKZ | PCT/US99/18149 |
97 | EP publication number | EPN | 1104436 |
87 | WO publication number | WPN | 2000009531 |
54 | Designation/title | TI | BETA-L-2'-DEOXYNUKLEOSIDE FÜR DIE BEHANDLUNG VON HEPATITIS B VIRUS |
51 | IPC main class | ICM (ICMV) | C07H 19/06 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07H 19/10 (2006.01), C07H 19/16 (2006.01), C07H 19/20 (2006.01), A61K 31/70 (2006.01), A61P 31/12 (2006.01) |
22 | DE application date | DAT | Aug 10, 1999 |
96 | EP application date | EAT | Aug 10, 1999 |
86 | WO application date | WAT | Aug 10, 1999 |
43 | Date of first publication | OT | Feb 24, 2000 |
| Date of publication of grant | PET | Dec 21, 2005 |
71/73 | Applicant/owner | INH | Centre National de la Recherche Scientifique, 75794 Paris, FR; Novartis AG, 4056 Basel, CH; Université de Montpellier, 34090 Montpellier, FR |
72 | Inventor | IN | GOSSELIN, Gilles, 34080 Montpellier, FR; IMBACH, Jean-Louis, 34000 Montpellier, FR; BRYANT L., Martin, Carlisle, US |
74 | Representative | VTR | IP2 Patentanwalts GmbH, 41238 Mönchengladbach, DE |
10 | Published DE documents | DEPN | Original document:
DE000069929060T2 Searchable text:
DE000069929060T2 |
| Address for service | | IP2 Patentanwalts GmbH, 41238 Mönchengladbach, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 96110 P Aug 10, 1998
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 131352 P Apr 28, 1999
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2007 000 062.6 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
81 | Designated WO countries | WDS | RO |
| Published EP/WO documents | EPWOPN | Original document:
EP000001104436 Searchable text:
EP000001104436 Original document:
EP000001104436B1 Searchable text:
EP000001104436B1 Original document:
WO002000009531 Searchable text:
WO002000009531 |
43 | Date of first publication | EVT | Feb 24, 2000 |
| Date of the first transfer into DPMAregister | EREGT | Sep 30, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 30, 2022 (Show all update days)(Hide all update days)- Apr 30, 2022; Jan 2, 2020; Dec 7, 2019; Aug 13, 2019; Oct 26, 2018; Aug 17, 2018; Aug 12, 2017; Mar 9, 2017; Feb 1, 2017; Jan 31, 2017; Aug 13, 2016; Sep 9, 2015; Sep 5, 2015; Aug 25, 2015; Aug 14, 2015; Aug 20, 2014; Sep 25, 2013; Sep 13, 2013; Sep 12, 2013; Sep 11, 2013; Sep 5, 2013; Aug 31, 2013; Aug 30, 2013; Aug 16, 2013; Aug 2, 2013; Aug 1, 2013; Jul 30, 2013; Jul 9, 2013; Jun 14, 2013; Jun 13, 2013; Jun 11, 2013; May 28, 2013; May 14, 2013; May 7, 2013; Apr 30, 2013; Apr 27, 2013; Jan 23, 2013
- Historical data not available for this/these date(s)
- Sep 30, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 13)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Feb 27, 2012 |
| Issue number | HN | 16 |
| Year | PJ | 2012 |
| Publication date | VT | Apr 19, 2012 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris Cédex, FR; Idenix Pharmaceuticals, Inc., Cambridge, Mass., US; L'Université Montpellier II, Montpellier, FR |
71/73 | Previous applicant/owner | INHF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris Cédex, FR, Idenix (Cayman) Ltd., Grand Cayman, KY, L'Université Montpellier II, Montpellier, FR |
View procedures New applicant/owner details (No.: 14)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 12, 2013 |
| Issue number | HN | 31 |
| Year | PJ | 2013 |
| Publication date | VT | Aug 1, 2013 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris Cédex, FR; L'Université Montpellier II, Montpellier, FR; Novartis AG, 4056 Basel, CH |
71/73 | Previous applicant/owner | INHF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris Cédex, FR, Idenix Pharmaceuticals, Inc., Cambridge, Mass., US, L'Université Montpellier II, Montpellier, FR |
View procedures New applicant/owner details (No.: 16)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jan 31, 2017 |
| Issue number | HN | 10 |
| Year | PJ | 2017 |
| Publication date | VT | Mar 9, 2017 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Centre National de la Recherche Scientifique, 75794 Paris, FR; Novartis AG, 4056 Basel, CH; Université de Montpellier, 34090 Montpellier, FR |
71/73 | Previous applicant/owner | INHF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris Cédex, FR, L'Université Montpellier II, Montpellier, FR, Novartis AG, 4056 Basel, CH |